Matteo Giovanni Della Porta Selected Research

Matteo Giovanni Della Porta Research Topics

13	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2024 - 10/2005
8	Neoplasms (Cancer) 04/2024 - 04/2011
4	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 09/2004
2	COVID-19 02/2023 - 01/2023
2	Iron Overload 01/2023 - 03/2010
2	Disease Progression 01/2021 - 01/2017
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2020 - 10/2005
2	Anemia 10/2009 - 07/2008
1	Hematologic Neoplasms (Hematological Malignancy) 05/2024
1	Inflammation (Inflammations) 09/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Asthenia 01/2023
1	Body Weight (Weight, Body) 01/2023
1	Fatigue 01/2023
1	Headache (Headaches) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Thrombocytopenia (Thrombopenia) 01/2023
1	Nausea 01/2023
1	Neutropenia 01/2023
1	Syncope (Fainting) 01/2023
1	Thrombocytosis (Thrombocythemia) 11/2021
1	Polycythemia (Erythrocytosis) 11/2021
1	Multiple Myeloma 01/2021
1	Sideroblastic Anemia 10/2011
1	Refractory Anemia 10/2011
1	Starvation 10/2011
1	Heart Failure 04/2011
1	Cardiotoxicity 04/2011
1	Breast Neoplasms (Breast Cancer) 04/2011
1	Leukopenia 10/2009
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2009
1	Cytopenia 07/2008
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2005
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 09/2004

2	CytokinesIBA 09/2023 - 11/2021
2	luspaterceptIBA 01/2023 - 01/2023
2	ruxolitinibIBA 01/2022 - 11/2019
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 10/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 04/2011
2	Ferritins (Ferritin)IBA 10/2011 - 03/2010
1	RNA Splicing FactorsIBA 04/2024
1	ChemokinesIBA 09/2023
1	HematinicsIBA 01/2023
1	Epoetin Alfa (Epogen)FDA Link 01/2023
1	daratumumabIBA 01/2021
1	Bortezomib (Velcade)FDA Link 01/2021
1	AntibodiesIBA 11/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Immune Checkpoint ProteinsIBA 01/2019
1	TrabectedinIBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 12/2011
1	IronIBA 10/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2011
1	Bevacizumab (Avastin)FDA Link 04/2011
1	Lapatinib (GW572016)FDA Link 04/2011
1	Sunitinib (Sutent)FDA Link 04/2011
1	Phosphotransferases (Kinase)IBA 04/2011
1	Trastuzumab (Herceptin)FDA Link 04/2011
1	Sorafenib (BAY 43-9006)FDA Link 04/2011
1	EnzymesIBA 10/2009
1	Methotrexate (Mexate)FDA LinkGeneric 10/2009
1	Thymidylate SynthaseIBA 10/2009
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2009
1	Folic Acid AntagonistsIBA 10/2009
1	Erythropoietin FDA Link 07/2008
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2008
1	Metalloproteases (Metalloproteinases)IBA 03/2008
1	Matrix Metalloproteinases (MMPs)IBA 03/2008
1	Messenger RNA (mRNA)IBA 09/2004

7	Therapeutics 05/2024 - 10/2009
5	Drug Therapy (Chemotherapy) 01/2021 - 10/2009
4	Stem Cell Transplantation 05/2024 - 08/2008
2	Hematopoietic Stem Cell Transplantation 05/2024 - 05/2024
2	Immunotherapy 11/2019 - 01/2019
2	Transplantation 07/2013 - 03/2010
1	Erythrocyte Transfusion 01/2023
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2005
1	Splenectomy 01/2005